Published in Clin Sci on November 01, 1970
Intravascular coagulation and E. coli septicaemia. J Clin Pathol (1973) 1.18
Immunofluorescent studies on alpha 2-plasmin inhibitor (alpha 2-PI) in glomeruli from patients with IgA nephropathy. Clin Exp Immunol (1985) 0.82
The fibrinolytic enzyme system in hypertension. J Clin Pathol (1973) 0.75
The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med (1969) 2.39
Attitudes of patients to clinical teaching. Br J Med Educ (1967) 2.28
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest (1969) 2.14
Postgraduate medical degrees of the University of Aberdeen, 1931-69. Scott Med J (1970) 1.64
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol (1966) 1.55
Venous thrombosis following strokes. Lancet (1972) 1.46
Familial thrombosis: inherited deficiency of antithrombin III. Br Med J (1978) 1.40
Studies on the blood fibrinolytic enzyme system following acute myocardial infarction. Clin Sci (1967) 1.26
Further medical education of Aberdeen graduates 1956-58. Br J Med Educ (1969) 1.18
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. Br Med J (1976) 1.15
The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor). Br J Haematol (1971) 1.12
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet (1973) 1.11
Serum Mucoproteins and Plasma Fibrinolytic Activity in Coronary-artery Disease. Br Med J (1962) 1.10
The relationship between platelet aggregation and time interval after venepuncture. Thromb Diath Haemorrh (1974) 1.08
Present employment of University of Aberdeen medical graduates, 1956-58. Lancet (1969) 1.06
A method for the quantitative assay of inhibitor of plasminogen activation in human serum. Thromb Diath Haemorrh (1967) 1.02
The inhibition of urokinase by alpha 2 -macroglobulin. Clin Sci (1973) 0.97
The plasminogen content of thrombi. Thromb Diath Haemorrh (1966) 0.96
Studies on the fibrinolytic enzyme system in obesity. J Clin Pathol (1966) 0.94
The metabolism of Plasmodium berghei, the malaria parasite of rodents. 2. An effect of mepacrine on the metabolism of glucose by the parasite separated from its host cell. Biochem J (1961) 0.93
Evaluation of diagnostic significance of certain symptoms and physical signs in anaemic patients. Br Med J (1969) 0.92
Effect of oestriol on platelet adhesiveness and fibrinolysis in men. Lancet (1966) 0.91
Psychogenic purpura. Br Med J (1971) 0.91
Effect of exercise on platelet count, adhesion, and aggregation. Acta Haematol (1974) 0.91
Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity. J Clin Pathol (1972) 0.90
Factors influencing the prognosis in myelomatosis. Postgrad Med J (1971) 0.90
Deep venous thrombosis of the legs after strokes: Part 2-Natural history. Br Med J (1976) 0.90
High incidence of myelomatosis in North-East Scotland. Scott Med J (1973) 0.90
Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol (1976) 0.90
The inhibition of tissue activator and urokinase by human plasma. Thromb Haemost (1982) 0.88
Methotrexate and the platelet count. Br J Cancer (1968) 0.88
Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein. Br Med Bull (1978) 0.87
Effect of glycosaminoglycans on thrombin-induced clotting of normal and antithrombin III-deficient plasmas. Thromb Res (1980) 0.87
Coagulation and fibrinolysis in thyroid disease. Acta Haematol (1978) 0.87
The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium. Thromb Haemost (1983) 0.86
The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases. J Clin Pathol (1971) 0.86
Arcus senilis and coronary artery disease. Am Heart J (1965) 0.85
Studies on an inhibitor of plasminogen activators in human platelets. Br J Haematol (1974) 0.85
The contribution of plasma protease inhibitors to antiplasmin activity in man. Clin Sci Mol Med (1976) 0.84
Phenotypic abnormality of T cells in B cell non-Hodgkin's lymphoma. Dis Markers (1991) 0.84
Blood levels of proteinase inhibitors in pre-eclampsia. Br J Obstet Gynaecol (1983) 0.83
Inhibitors of plasminogen activation in human blood. Br J Haematol (1976) 0.83
Blood levels of proteinase inhibitors in pregnancy. Br J Obstet Gynaecol (1982) 0.83
Changes in protease inhibitors after acute myocardial infarction. J Clin Pathol (1976) 0.82
The action of antithrombin III on plasmin and activators of plasminogen. Biochim Biophys Acta (1975) 0.82
Arterio-venous differences in the components of the fibrinolytic enzyme system. Thromb Diath Haemorrh (1966) 0.81
The thyroid and fibrinolysis. Br Med J (1967) 0.81
The effect of age on the fibrinolytic enzyme system. J Clin Pathol (1974) 0.80
C1 inactivator level in pregnancy. Thromb Res (1982) 0.80
The influence of alpha-1-antitrypsin on plasmin, urokinase and Hageman factor cofactor. Biochim Biophys Acta (1974) 0.80
Protease inhibitors in liver disease. Scand J Gastroenterol (1988) 0.80
The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythaemia vera. Postgrad Med J (1970) 0.80
Properties of a partially purified preparation of a circulating plasminogen activator. Thromb Res (1976) 0.79
Urokinase in iliofemoral venous thrombosis. Br J Surg (1969) 0.79
The fibrinolytic system in pre-eclampsia. J Clin Pathol (1984) 0.77
The effect of age upon the coagulation system. J Clin Pathol (1974) 0.77
Platelet adhesiveness and fibrinolysis after recent cerebro-vascular accidents and their relationship with subsequent deep venous thrombosis of the legs. Thromb Haemost (1976) 0.77
The influence of the polyphenols of cider on plasmin and plasminogen activators. Br J Haematol (1985) 0.76
The effeCt of vitamin c supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness. Atherosclerosis (1975) 0.76
The effect of prolonged exercise on the components of the blood fibrinolytic enzyme system. J Physiol (1968) 0.76
An evaluation of the diagnostic significance of some symptoms and physical signs in chronic iron-deficiency anaemia. Proc Nutr Soc (1969) 0.76
Changes in coagulation factors following acute myocardial infarction in man. Haemostasis (1976) 0.76
Thrombocytosis following thrombocytopenia in man. Postgrad Med J (1969) 0.75
Biochemistry of the plasmin system. J Clin Pathol Suppl (R Coll Pathol) (1980) 0.75
Non-cytotoxic antibodies in chronic lymphocytic leukaemia. J Clin Pathol (1987) 0.75
The fibrinolytic enzyme system in hypertension. J Clin Pathol (1973) 0.75
Fibrinolytic activity in malignant disease. J Clin Pathol (1975) 0.75
Origin and employment of the medical graduates of the University of Aberdeen 1931-69. Br Med J (1970) 0.75
Fibrinolytic capacity of arm and leg veins after femoral shaft fracture and acute myocardial infarction. Br Med J (1975) 0.75
Fibrinolysis in leukaemia. J Clin Pathol (1968) 0.75
Effect of local exercise and vessel occlusion on fibrinolytic activity. J Clin Pathol (1977) 0.75
Clinical physiology of the fibrinolytic enzyme system. J Clin Pathol (1972) 0.75
The fibrinolytic enzyme system in leukaemia, myelomatosis and myeloproliferative diseases. Acta Haematol (1972) 0.75
A Scottish Hebridean antithrombin III deficient family--twelve years on. Scott Med J (1990) 0.75
Studies on the blood fibrinolytic system in congestive cardiac failure. Clin Sci (1973) 0.75
Inhibition of the activated Cls subunit of the first component of complement by antithrombin III in the presence of heparin. Thromb Res (1976) 0.75
Paralysis of the legs and venous thromboembolism. Am Heart J (1973) 0.75
Inhibitors of fibrinolysis in amniotic fluid. Thromb Haemost (1980) 0.75
The influence of personality on student reactions to clinical experience. J Med Educ (1972) 0.75
Anticoagulant and thrombolytic drugs. II. Clinical aspects. Drugs (1971) 0.75
The fibrinolytic enzyme system in anorexia nervosa. Acta Haematol (1976) 0.75
Effect of low-density lipoprotein preparations on plasmin. Clin Sci (1973) 0.75
Interrelations between ABO blood group, plasminogen, alpha1-antitrypsin, alpha2-macroglobulin and the platelet count in blood donors. Acta Haematol (1976) 0.75
Proceedings: Studies on circulating plasminogen activator. Thromb Diath Haemorrh (1975) 0.75
Platelet function after the administration of chlorpromazine to human subjects. Haemostasis (1976) 0.75
The fibrinolytic enzyme system in malignant lymphomas. Acta Haematol (1973) 0.75
The effect of age on the diagnostic value of greying of the hair in addisonian pernicious anaemia. Gerontol Clin (Basel) (1972) 0.75
Further purification and properties of Hageman factor cofactor. Biochim Biophys Acta (1972) 0.75
Inhibition of the plasminogen activator urokinase by alpha-tocopherol. Acta Haematol (1982) 0.75
The effect of clofibrate on components of the fibrinolytic enzyme system. Atherosclerosis (1973) 0.75
Properties of plasma plasminogen activators [proceedings]. J Physiol (1978) 0.75
Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects. Drugs (1971) 0.75